Hope • June 9, 2026
Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
Originally published on Good News Network
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a year to people in a high-HIV-incidence country, which
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a year to people in a high-HIV-incidence country, which
Originally published on Good News Network.
More good news
- A little kid snuck into his older brother’s game and somehow ended up getting his very first red card.
- Fairies 🧚
- (OC) I won the parents lottery! They are soon celebrating their 58th wedding anniversary. They always put me and my late brother Brett first. They've given me everything, even when I didn't deserve it. Tragedy only made them closer, and the good times far outweigh the bad. I love them so much!
- The hat my wife and kids handmade me for Father's Day